Forget Aurora (TSX:ACB): This Weed Stock Can Go Bonanza

With the possibility of being overvalued looming over Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB), you can expect the stock to depreciate in value. Luckily, lesser-known Green Organic Dutchman Holdings Ltd (TSX:TGOD) offers potential as a viable replacement.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aurora Cannabis (TSX:ACB)(NYSE:ACB) will likely release its quarterly performance results in September. With edibles soon to be legalized in the country, there are potentially positive signs for the company in terms of its revenue numbers. Aurora is expected to retain one of the top spots in Canada’s cannabis industry.

While the prospects for the company in terms of sales revenue look good, you should know that Aurora still might not lead to a good investment for you today. While the sales may increase, the company is not likely to make improvements in its cash flow.

Aurora could face restrictions on what it can and cannot do, while also taking care of the interest charges on its debt. The company’s alternative to that would be issuing more shares. That spells bad news for existing investors, since the dilution will keep the share prices from increasing in value.

Things are still looking up for weed stocks, but you might want to consider something other than Aurora if you’re going to make the most of your investments. Perhaps consider the little-known Green Organic Dutchman Holdings (TSX:TGOD).

The state of affairs for Green Organic

Green Organic is a mid-tier player in the Canadian marijuana industry that has massive potential for high returns. TGOD wants to establish itself as a leader in the cannabis industry for premium quality organic cannabis products. It has a unique vision, which is concise and can help the company carve out a niche within an increasingly crowded industry.

Green Organic is an international medical and adult-use cannabis enterprise that operates in Canada, Europe, the Caribbean, and Latin America. The company released its Q2 2019 earnings in August, which show positive signs. Green Organic achieved revenues of $2.9 million, a 20% increase over the prior quarter derived mainly from Europe.

While TGOD experienced a net loss of $16.6 million for Q2 2019, the management continues to keep a disciplined approach towards investing in its operational costs to prepare the company for commercializing its products in Canada and international markets.

Its entry into a multi-year agreement with Neptune Wellness Solutions for extraction, formulation, and packaging services presents favourable news for the company. Green Organic will retain exclusivity in the packaging, extraction, and formulation of certified organic products in the Canadian market as part of this deal with Neptune.

Is Green Organic a better alternative to Aurora?

The price of TGOD stands at $3.18 at the time of writing — less than half of Aurora at $7.68. With a lower price and higher potential for growth, I would say that Green Organic is a better weed stock to consider investing in compared to Aurora, which may well be overvalued right now.

Green Organic is aiming to become a market leader in premium and organic cannabis and is well on the way of achieving it. Despite recent setbacks, the company offers interesting play for cannabis investors who want to capitalize on the burgeoning weed industry but do not want to go down a well-trodden path.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »